Add-On Fruquintinib Delays Progression in Gastric Cancer Add-On Fruquintinib Delays Progression in Gastric Cancer
Fruquintinib plus paclitaxel improves cancer progression-free, but not overall survival, in patients with gastric/gastroesophageal cancer who have progressed on frontline chemotherapy.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Gastric (Stomach) Cancer | Gastroenterology | Hematology